StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Sector-similar peers via Finnhub · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | ORKA ORKA | $60.63 | +3.31% | $3.7B | — | 78.4 | — | — | — |
| 1 | TWST Twist Bioscience | $60.59 | +2.98% | $3.8B | — | 9.2 | +17.8% | 52.1% | 56 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $30.90 |
| +0.72% |
| $3.5B |
| — |
| — |
| — |
| — |
| 38 |
| 3 | ACAD Acadia Pharmaceuticals | $21.11 | -0.98% | $3.7B | 9.4 | 4.4 | -13.6% | 91.7% | 37 |
| 4 | VCYT Veracyte | $45.04 | -0.33% | $3.3B | 37.8 | 6.1 | +16.9% | 70.9% | 34 |
| 5 | CAI CAI | $15.56 | -2.38% | $4.4B | — | 5.4 | — | 66.4% | — |
| 6 | TVTX TVTX | $44.44 | -0.67% | $4.1B | — | 7.7 | +96.0% | 98.6% | — |
| 7 | CPRX CPRX | $31.27 | -0.03% | $3.8B | 17.3 | 6.4 | +11.7% | 86.0% | — |
| 8 | ERAS ERAS | $11.25 | -3.06% | $3.6B | — | — | — | — | — |
| 9 | DNLI DNLI | $18.65 | -3.37% | $3.0B | — | 8.7 | — | — | — |